
Adipogen/AS-703026/SYN-1190-M010/10 mg
商品编号:
SYN-1190-M010
品牌:
Adipogen Inc
市场价:
¥2600.00
美元价:
1560.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | AS703026 |
ProductType | Chemical |
Properties | |
Formula | C15H15FIN3O3 |
MW | 431.2 |
CAS | 1236699-92-5 |
PurityChemicals | ≥95% |
Appearance | Solid. |
Solubility | SolubleinDMSO.Slightlysoluble(<1mg l)="" in="" ethanol.="">1mg> |
Declaration | ManufacturedbySynKinase. |
OtherProductData | Target:MEK1-MEK2|KinaseGroup:STE|Substrate:Serine-Threonine ClickhereforOriginalManufacturerProductDatasheet Ourproductdescriptionmaydifferslightlyfromtheoriginalmanufacturersproductdatasheet. |
InChiKey | VIUAUNHCRHHYNE-JTQLQIEISA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | +4°C |
Use/StABIlity | Stableforatleast1yearafterreceiptwhenstoredat+4°C. |
Documents | |
MSDS | ![]() |
ProductSpecificationSheet | |
Datasheet | ![]() |
AS703026isanovel,selective,non-competitive,orallybioavailableMEK1/2inhibitorwithexperimentalIC(50)valuesof5-11nM.Inuseonmultiplemyelomacells(MM),AS703026inhibitedgrowthandsurvivalofMMcellsandcytokine-inducedosteoclastdifferentiationmorepotently(~10X)thanAZD6244.InhibitionofproliferationinducedbyAS703026wasmediatedbyG0-G1cellcyclearrestandwasaccompaniedbyreductionofMAFoncogeneexpression.AS703026furtherinducedapoptosisviacaspase3andPolyADPribosepolymerase(PARP)cleavageinMMcells,bothinthepresenceorabsenceofbonemarrowstromalcells(BMSCs).Importantly,AS703026sensitizedMMcellstoabroadspectrumofconventional(dexamethasone,melphalan),noveloremerging(lenalidomide,perifosine,bortezomib,rapamycin)anti-MMtherapies.SignificanttumourgrowthreductioninAS703026-vs.vehicle-treatedmicebearingH929MMxenografttumourscorrelatedwithdownregulatedpERK1/2,inducedPARPcleavage,anddecreasedmicrovesselsinvivo.Moreover,AS703026(<200nm) was="" cytotoxic="" against="" the="" majority="" of="" tumour="" cells="" tested="" from="" patients="" with="" relapsed="" and="" refractory="" mm="" (84%),="" regardless="" of="" mutational="" status="" of="" ras="" and="" braf="" genes.="" importantly,="" bmsc-induced="" viability="" of="" mm="" patient="" cells="" was="" similarly="" blocked="" within="" the="" same="" dose="">200nm)>
ProductReferences
- BlockadeoftheMEK/ERKsignallingcascadebyAS703026,anovelselectiveMEK1/2inhibitor,inducespleiotropicanti-myelomaactivityinvitroandinvivo:K.Kim,etal.;Br.J.Haematol.149,537(2010)
- MEK1/2inhibitorsAS703026andAZD6244maybepotentialtherapiesforKRASmutatedcolorectalcancerthatisresistanttoEGFRmonoclonalantibodytherapy:J.Yoon,etal.;J.CancerRes.71,445(2011)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们